HIGHLIGHTS
- who: James H. A. Clubb and collaborators from the Department of Neurosurgery, Capital Medical University, China have published the paper: Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting, in the Journal: (JOURNAL)
- what: The authors show their utility of these mAb clones for co-cultures, enzyme-linked immunosorbent assay (ELISA), immunohistochemistry (IHC) and flow cytometry. The analysis shows that 12F1-1, when compared to 11B12-1, binds more stably and rigidly to its epitope. This experiment showed that 11B12-1 and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.